Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $6 billion (+11.1%)
Orthopedics: $2.2 billion (+2%)
Hips: $466 million (+8.9%)
Knees: $640 million (+6.3%)
Spine: $5 million
Net earnings: $884 million
Total sales: $2.07 billion (+7%)
Hips: $536.1 million (+5.8%)
Knees: $826 million (+3.1%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $550.6 million (+17.3%)
Net earnings: $152.8 million
Medtech sales: $8.5 billion (+7.3%)
Orthopedic: $2.3 billion (-3%)
Spine, sports and other: $727 million (-2.1%)
Hips: $421 million (+1%)
Knees: $389 million (-1.1%)
Net earnings: $5.5 billion
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
